Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-12-03 13:33Core Viewpoint - The stock of Steady Medical (300888) has shown a decline in price and mixed capital flow, with significant net outflows from major and retail investors, while institutional ratings remain predominantly positive [1][4]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main revenue of 7.897 billion yuan, a year-on-year increase of 30.1% [3] - The net profit attributable to shareholders was 732 million yuan, up 32.36% year-on-year [3] - The third quarter alone saw a main revenue of 2.601 billion yuan, a 27.71% increase year-on-year, and a net profit of 240 million yuan, up 42.11% year-on-year [3] - The company’s gross margin stands at 48.32%, which is higher than the industry average of 42.35% [3] Market Position - Steady Medical has a total market capitalization of 22.827 billion yuan, ranking third in the beauty and personal care industry [3] - The company has a net asset value of 12.263 billion yuan, ranking first in the industry [3] - The price-to-earnings ratio (P/E) is 23.39, which is lower than the industry average of 37.76, indicating a potentially undervalued stock [3] Capital Flow Analysis - On December 3, 2025, the stock closed at 39.2 yuan, down 0.63%, with a turnover rate of 0.38% and a trading volume of 22,200 hands [1] - The net outflow of major funds was 5.631 million yuan, accounting for 6.44% of the total trading volume, while retail investors saw a net inflow of 12.1146 million yuan, representing 13.86% of the total [1][2] Institutional Ratings - In the last 90 days, 20 institutions have rated the stock, with 17 buy ratings and 3 hold ratings [4] - The average target price set by institutions over the past 90 days is 5.488 billion yuan [4]